medigraphic.com
ISSN 0185-3325 (Impreso)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2013, Número 2

<< Anterior Siguiente >>

Salud Mental 2013; 36 (2)


El problema del consumo de cannabis: el papel del Sector Salud

del Bosque J, Fernández C, Sánchez HR, Díaz DB, Gutiérrez LAD, Fuentes MA, Espínola M, González GN, Loredo AA, Medina-Mora ME, Alvarado RN, Natera G, Real T, Sansores R, Prospéro-García O, Zinser J, Suárez C, Beltrán A

Idioma: Español
Referencias bibliográficas: 55
Paginas: 149-158
Archivo PDF: 257.28 Kb.


FRAGMENTO

La Cannabis ha sido objeto de importante debate internacional. Algunas voces que proponen la legalización suponen que esta medida quitaría ganancias a los traficantes y existe consenso de que su consumo no debe de ser motivo de encarcelamiento.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Babor T, Miller P, Edwards G. Vested interests, addiction research and public policy. Addiction 2010;105(1):4-5.

  2. National Institute on Drug Abuse (NIDA). Abuso de la marihuana. Disponible en línea: http://www.nida.nih.gov/ResearchReports/Marihuana/ default.html (recuperado en 2011).

  3. Méndez M, Ruiz AE, Prieto B, Romano A et al. El cerebro y las drogas, sus mecanismos neurobiológicos. Salud Mental 2010;33:451-456.

  4. Cravatt DF, Prospéro-García O, Siuzdak G, Gilula NB, et al. Chemical characterization of a family of brain lipids that induce sleep. Science 1995;268:1506-1509.

  5. Di Marzo V, Bifulco M, De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nature Rev. Drug Discovery 2004:3:771-784.

  6. Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology Reviews 2010;35:217-238.

  7. Ruiz AE, Méndez M, Prieto Gómez B, Romano A et al. El cerebro, las drogas y los genes. Salud Mental 2010;33:535-542.

  8. Dumontheil I, Burgess PW, Blakemore S-J. Development of rostral prefrontal cortex and cognitive and behavioral disorders. Dev Med Child Neurol 2008;50:168-181.

  9. Benjet C, Borges G, Méndez E, Fleiz C, Medina-Mora ME. The association of chronic adversity with psychiatric disorder and disorder severity in adolescents. Eur Child Adolesc Psychiatry 2011;20(9):459-468.

  10. Fergusson D, Boden J, Horwood L. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction 2006;101(4):556-569.

  11. Fergusson D , Boden J, Horwood L. The developmental antecedents of illicit drug use: Evidence from a 25-year longitudinal study. Drug Alcohol Depend 2008;96(1-2): 165-177.

  12. Arellanez J, Diaz D Wagner F, Pérez V. Factores psicosociales asociados con el abuso y la dependencia de drogas entre adolescentes: Análisis bivariados de un estudio de casos y controles. Salud Mental 2004;27(3):54-64.

  13. Rodríguez S, Diaz B, Gracia S, Guerrero A. Capacidad predictiva de la Teoría de la Conducta Planificada en la intención y uso de drogas ilícitas entre estudiantes mexicanos. Salud Mental 2007;30(1):68-81.

  14. Newman K, Harrison L, Dashiff C, Davies S. Relationships between parenting styles and risk behaviors in adolescent health: an integrative literature review. Rev Lat Am Enfermagem 2008;16(1):142-150.

  15. Lloyd DA, Turner RJ. Cumulative life-time adversities and alcohol dependence in adolescence and young adulthood. Drug Alcohol Depend 2008;93:217–226.

  16. Sartor C, Lynskey M, Bucholz K, McCutcheon V et al. Childhood sexual abuse and the course of alcohol dependence development: Findings from a female twin sample. Heath Drug Alcohol Depend 2007;89(2-3):139–144.

  17. Kwok-Kei Mak, Sai-Yin Ho, Neil Thomas G, Schooling CM et al. Family structure, parent-child conversation time and substance use among Chinese adolescents. BMC Public Health 2010;10:503.

  18. Lynskey M, Vink J, Boomsma D. Early onset cannabis use and progression to other drug use in a sample of Dutch twins, Behavior Genetics 2006;36(2):195-200.

  19. Russell K, Dryden DM, Yuanyuan Liang, Friesen C et al. Risk factors for methamphetamine use in youth: a systematic review. BMC Pediatrics 2008;8:48 doi:10.1186/1471-2431-8-48.

  20. Bretteville-Jensen A, Melberg H, Jones A. Sequential patterns of drug use initiation, Can we relieve in the gateway theory? BE J Econom Analysis Policy 2008;8(2): 1846-1846.

  21. Wu B, Mao ZF, Rockett IR, Yue Y. Socioeconomic status and alcohol use among urban and rural residents in China. Subst Use Misuse 2008;43(7):952-966.

  22. Chuan-Yu Chen, Storr C, Anthony J. Early-onset drug use and risk for drug dependence problems. Addict Behav 2009;34(3):319–322.

  23. McLaughlin K, Greif Green J, Gruber M, Sampson N et al. Childhood adversities and adult psychopathology in the National Comorbidity Survey Replication (NCS-R) II: Associations with persistence of DSM-IV disorders. Arch Gen Psychiatry 2010;67(2):124–132.

  24. Diaz N, Arellanez J, Martínez J. Uso de drogas y factores psicosociales asociados entre estudiantes de educación media básica del estado de Nuevo León. En: Secretaría de Salud, CONADIC. Observatorio mexicano en tabaco, alcohol y otras drogas. México: SSA, CONADIC. 2002; pp. 133-136.

  25. Diaz N, García R. Factores psicosociales de riesgo de consumo de drogas ilícitas en una muestra de estudiantes mexicanos de educación media. Rev Panam Salud Pública 2008;24(4):223-232.

  26. Sánchez H, Guisa V, Ortiz R, de Leó G. Detección temprana de factores de riesgo para el consumo de sustancias ilícitas. Salud Mental 2002;25(3):1-11.

  27. Secretaría de Salud. Encuesta Nacional de Adicciones 2008. México: Instituto Nacional de Salud Pública; 2008.

  28. Villatoro J, Gaytán F, Moreno M, Gutiérrez ML et al. Consumo de alcohol, tabaco y otras drogas en la ciudad de México. Medición 2009. México: Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz; 2010.

  29. Sistema de Información Epidemiológica del Consumo de Drogas. SIECD (2011). Consumo de drogas en pacientes de primer ingreso a tratamiento en Centros de Integración Juvenil, enero–junio de 2010. México: Centros de Integración Juvenil; 2011.

  30. English DR, Hulse GK, Milne E, Holman CD. Maternal cannabis use and birth weight: A meta-analysis. Addiction 1997;92:1553-1560.

  31. Rivkin MJ, Davis PE, Lemaster JI, Cabral HJ. Volumetric MRI study of brain in children with intrauterine exposure to cocaine, alcohol, tobacco and marijuana. Pediatrics 2008;121:741-750.

  32. Campolongo P, Trezza V, Ratano P, Palmery M. Developmental consequences of perinatal cannabis exposure: behavioral, and neuroendocrine effects in adult roedents. Psychopharmacology 2011;214:5-15.

  33. Day N, Leech S, Goldschmidt L. The effects of prenatal marijuana exposure on delinquent behaviors are mediated by measures of neurocognitive functioning. Neurotoxicology Teratology 2011;1:129-136.

  34. McKay DR, Tennant CC. Is de grass greener? The link between cannabis and psychosis. Med J Aust 2000;172:284-286.

  35. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009;17:(9698):1383-1391.

  36. Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987;2:1483-1486.

  37. Zammit S, Allebeck P, Andreasson S, Lundberg I et al. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. Br Med J 2002;325:1199-1201.

  38. Bovasso GB. Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry 2001;158:2033-2037.

  39. Rey J. Cannabis and mental health. Br Med J 2002;325: 1183-1184.

  40. Van Os J, Bak M, Hanssen M, Biji RV et al. Cannabis use and psychosis: A longitudinal population-based study. Am J Epidemiol 2002;156:319-327.

  41. Arsenault L, Cannon M, Poulton R, Murray R et al. Cannabis use in adolescent and risk for adult psychosis: longitudinal prospective study. Br MedJ 2002;325:1212-1213.

  42. Marihuana. Canada: Information for health care professionales; 2010.

  43. Aldington S, Williams M, Nowitz M, Weatherall M et al. Effects of cannabis on pulmonary structure, function and symptoms. Thorax 2007;62:1058-1063.

  44. Hancox RJ, Poulton R, Ely M, Welch D et al. Effects of cannabis on lung function: a population-based cohort study. Eur Respir J 2010;35:42-47.

  45. Aldington S, Harwood M, Cox B, Weatherall M et al. Cannabis use and risk of lung cancer: a case-control study. Eur Respir J 2008;31:280-286.

  46. Armentia A, Castrodeza J, Ruiz-Muñoz P, Martínez-Quesada J et al. Allergic hypersensitivity to cannabis in patients with allergy and illicit drug users. Allergol Immunopathol (Madr) 2011;39(5):271-279.

  47. Cho CM, Hirsch R, Johnstone S. General and oral health implications of cannabis use. Aust Dent J 2005;50:70-74.

  48. Versteeg PA, Slot DE, van der Velden U, van der Weijden GA. Effect of cannabis usage on the oral environment: a review. Int J Dent Hyg 2008;6:315-320.

  49. Zhang ZF, Morgenstern H, Spitz MR, Tashkin DP et al. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 1999;8:1071-1078.

  50. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009;374(9698):1383-1391.

  51. Shamloul R, Bella AJ. Impact of cannabis use on male sexual health. J Sex Med 2011;8:971-975.

  52. National Institute on Drug Abuse (NIDA). Abuso de la marihuana. Disponible en línea: http://www.nida.nih.gov/ResearchReports/Marihuana/ default.html

  53. The Monitoring the Future study. Michigan: The University of Michigan; 2008.

  54. MacCoun R, Reuter P. Interpreting dutch cannabis policy: Reasoning by analogy in the legalization debate. Science 1997;278:47-52.

  55. Dolin B. National drug policy: The Netherlands. prepared for the senate special committee on illegal drugs. Law and Government Division; 2001.




2020     |     www.medigraphic.com